Journal of Clinical & Experimental OncologyISSN: 2324-9110

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Anil Kuman Badana Author

Subjects of specialization
Mucoepidermoid carcinoma, Breast cancer, Blood loss

Affiliation
Department of Biochemistry, Cancer Biology Lab, GIS, GITAM University, India

Biography

Anil Kuman Badana was working in the Department of Biochemistry, Cancer Biology Lab, GIS, GITAM University, India. He has more than 20 publications. His current research area related to osteoarthropathy. 


Publications

Research Article Subscription

Knockdown of CD151 Gene Expression Reduces Survival of Estrogen Receptor Positive Breast Cancer Cells

Author(s):

Gayatri Devi V, Anil Kuman Badana, Madhuri Ch, Murali Mohan P, Shailandra Naik, Bhaskar Reddy I, Seema Kumari and Rama Rao Malla

Tetraspnin CD151 is involved in proliferation, motility, and invasion. Yet, the role of CD151 in estrogen receptor positive breast cancer is not reported. In the present study, the role of CD151 in survival of ER positive cell line and the underlying molecular partners was reported. CD151 shRNA expression vector was transfected into MCF-7 cells and its efficacy was evaluated by RT-PCR. The capacity of proliferation, migration, and invasion, cell adhesion, angiogenesis of MCF-7 cells was diminished by the knockdown of CD151 via CD151 specific shRNA. It arrested the cell cycle at G2/M phase and induced the apoptosis. The expressions of c-myc, α3β1 integrin, IL-8, Ras, FAK and VEGF were reduced by knockdown of CD151. The results conclude that CD151 g... view moreĀ»

DOI: 10.4172/2324-9110.1000186

Abstract HTML PDF



Google Scholars / Researchers Sites

GET THE APP